Pseudoprogression and Hyperprogression as New Forms of Response to Immunotherapy

In conclusion, pseudoprogression and hyperprogression are both frequent types of responses under immunotherapy, and there is a need to better characterize these to improve the management of cancer patients. Treatment beyond progression should always be considered with caution and necessitates close clinical monitoring. In case of suspected hyperprogression, immunotherapy should be stopped early.
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research